4,120
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Trends of pulmonary fungal infections from 2013 to 2019: an AI-based real-world observational study in Guangzhou, China

, , , , , , , , , , , , & show all
Pages 450-460 | Received 11 Nov 2020, Accepted 21 Feb 2021, Published online: 13 Mar 2021

References

  • Limper AH, Knox KS, Sarosi GA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183(1):96–128.
  • Limper AH. The changing spectrum of fungal infections in pulmonary and critical care practice: clinical approach to diagnosis. Proc Am Thorac Soc. 2010 May;7(3):163–168.
  • Denning DW, Chakrabarti A. Pulmonary and sinus fungal diseases in non-immunocompromised patients. Lancet Infect Dis. 2017;17(11):e357–e366.
  • Latgé J-P, Chamilos G. Aspergillus fumigatus and Aspergillosis in 2019. Clin AspergMicrobiol Rev. 2019;33(1):e00140–18.
  • O’Halloran JA, Powderly WG, Spec A. Cryptococcosis today: it is not all about HIV infection. Curr Clin Microbiol Rep. 2017;4(2):88–95.
  • Chan JFW, Lau SKP, Yuen K-Y, et al. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients. Emerg Microbes Infect. 2016;5:e19.
  • Smith JA, Kauffman CA. Pulmonary fungal infections. Respirology. 2012;17(6):913–926.
  • Hu J, Perer A, Wang F, et al. Data driven analytics for personalized healthcare. In: Weaver CA, Ball MJ, Kim GR, editors. Healthcare information management systems: cases, strategies, and solutions. Cham: Springer International Publishing; 2016. p. 529–554.
  • Turchin A, Kolatkar NS, Grant RW, et al. Using regular expressions to abstract blood pressure and treatment intensification information from the text of physician notes. J Am Med Inform Assoc. 2006;13(6):691–695.
  • Liang H, Tsui BY, Ni H, et al. Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence. Nat Med. 2019;25(3):433–438.
  • NHC. Basic standard of medical record writing [5 April 2020]. Available from: http://www.nhc.gov.cn/yzygj/s3585u/201002/0517a82e35224ee0912a5d855a9d249f.shtml.
  • NHC. China public health information classification and basic data set standard [5 April 2020]. Available from: http://www.nhc.gov.cn/mohwsbwstjxxzx/s8553/200809/37854.shtml.
  • NHC. National Health and medical big data standards, safety and service management measures (Trial) [5 April 2020]. Available from: http://www.nhc.gov.cn/guihuaxxs/s10741/201809/758ec2f510c74683b9c4ab4ffbe46557.shtml.
  • Zilberberg MD, Nathanson BH, Harrington R, et al. Epidemiology and outcomes of hospitalizations with invasive aspergillosis in the United States, 2009-2013. Clin Infect Dis. 2018 Sep 1;67(5):727–735.
  • Webb BJ, Ferraro JP, Rea S, et al. Epidemiology and clinical features of invasive fungal infection in a US Health care network. Open Forum Infect Dis. 2018;5(8):ofy187.
  • Shaheen AAM, Somayaji R, Myers R, et al. Epidemiology and trends of cryptococcosis in the United States from 2000 to 2007: a population-based study. Int J STD AIDS. 2018 Apr;29(5):453–460.
  • Tarka P, Nitsch-Osuch A, Gorynski P, et al. Epidemiology of pulmonary aspergillosis in hospitalized patients in Poland during 2009-2016. Adv Exp Med Biol. 2019;1160:73–80.
  • Escandón P, Lizarazo J, Agudelo CI, et al. Cryptococcosis in Colombia: compilation and analysis of data from laboratory-based surveillance. J Fungi (Basel). 2018;4(1):32.
  • The Lancet Child Adolescent H. Cancer in the young: progress and priorities. Lancet Child Adolesc Health. 2018;2(3):157.
  • Chen KY, Ko SC, Hsueh PR, et al. Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors. Chest. 2001;120(1):177–184.
  • Peng L, Xu Z, Huo Z, et al. New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in southwestern China. Infect Drug Resist. 2018;11:307–315.
  • Liu Y, She D, Sun T, et al. A multicentre retrospective study of pulmonary mycosis clinically proven from 1998 to 2007. Zhonghua Jie He He Hu Xi Za Zhi. 2011;34(2):86–90.
  • Vanittanakom N, Cooper CR, Fisher MC et al. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev 2006;19(9):5–110.
  • Gwinn M, MacCannell D, Armstrong GL. Next-generation sequencing of Infectious pathogens. Jama. 2019 Mar 5;321(9):893–894.
  • Simner PJ, Miller S, Carroll KC. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis. 2018;66(5):778–788.
  • Alanio A, Hauser PM, Lagrou K, et al. ECIL guidelines for the diagnosis of pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2386–2396.
  • Schelenz S, Barnes RA, Barton RC, et al. British Society for medical mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis. 2015;15(4):461–474.
  • Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and Treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367–1376.
  • Hage CA, Carmona EM, Epelbaum O, et al. Microbiological Laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019;200(5):535–550.
  • Groll AH, Shah PM, Mentzel C, et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect. 1996;33(1):23–32.
  • Dimopoulos G, Frantzeskaki F, Poulakou G, et al. Invasive aspergillosis in the intensive care unit. Ann N Y Acad Sci. 2012 Dec;1272:31–39.
  • Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782–792.
  • Sass G, Nazik H, Penner J, et al. Aspergillus-Pseudomonas interaction, relevant to competition in airways. Med Mycol. 2019;57((Supplement_2)):S228–S232.
  • Briard B, Mislin GLA, Latgé J-P, et al. Interactions between Aspergillus fumigatus and pulmonary bacteria: current State of the field, New data, and future perspective. J Fungi (Basel). 2019;5(2):48.
  • Briard B, Heddergott C, Latgé J-P. Volatile compounds emitted by Pseudomonas aeruginosa stimulate growth of the fungal pathogen Aspergillus fumigatus. mBio. 2016;7(2):e00219.
  • Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30(4):782–800.
  • Máiz L, Nieto R, Cantón R, et al. Fungi in bronchiectasis: a concise review. Int J Mol Sci. 2018;19(1):142.
  • Martin-Loeches I, Antonelli M, Cuenca-Estrella M, et al. ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients. Intensive Care Med. 2019;45(6):789–805.